High-dose Methylprednisolone and Rituximab in High Risk B-CLL - No Study Results Posted

High-dose Methylprednisolone and Rituximab in High Risk B-CLL (LT-CLL-001)

This study has been completed.

Study NCT00558181 Information provided by Vilnius University

First Received: November 13, 2007 Last Updated: February 22, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2009
Primary Completion Date:	January 2009 (Final data collection date for primary outcome measure)